Drug detection and analysis involve identifying the presence or absence of drugs in biological samples such as urine, blood, hair, breath, and sweat. They are often performed in clinical or workplace settings for medical reasons or as part of drug testing programs for law enforcement purposes.
The global market for Drug Detection and Analysis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Detection and Analysis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Drug Detection and Analysis by region & country, by Type, and by Application.
The Drug Detection and Analysis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Detection and Analysis.
麻豆原创 Segmentation
By Company
Element Materials Technology
Intertek
Microtrace LLC
LPD Lab Services
Reading Scientific Services
Triclinic Labs
Gateway Analytical
McCrone Group
Avomeen
ALS Global
SGS SA
Eurofins Scientific
Thermo Fisher Scientific
ChemCentre
PerkinElmer
TUV SUD
Bureau Veritas
Charles River Laboratories
Segment by Type:
Drug Impurity Detection and Analysis
Drug Contaminants Detection and Analysis
Segment by Application
Hospital
Laboratory
Pharmaceutical company
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drug Detection and Analysis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Drug Detection and Analysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Drug Detection and Analysis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Drug Detection and Analysis Product Introduction
1.2 Global Drug Detection and Analysis 麻豆原创 Size Forecast
1.3 Drug Detection and Analysis 麻豆原创 Trends & Drivers
1.3.1 Drug Detection and Analysis Industry Trends
1.3.2 Drug Detection and Analysis 麻豆原创 Drivers & Opportunity
1.3.3 Drug Detection and Analysis 麻豆原创 Challenges
1.3.4 Drug Detection and Analysis 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug Detection and Analysis Players Revenue Ranking (2023)
2.2 Global Drug Detection and Analysis Revenue by Company (2019-2024)
2.3 Key Companies Drug Detection and Analysis Manufacturing Base Distribution and Headquarters
2.4 Key Companies Drug Detection and Analysis Product Offered
2.5 Key Companies Time to Begin Mass Production of Drug Detection and Analysis
2.6 Drug Detection and Analysis 麻豆原创 Competitive Analysis
2.6.1 Drug Detection and Analysis 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Drug Detection and Analysis Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Detection and Analysis as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Drug Impurity Detection and Analysis
3.1.2 Drug Contaminants Detection and Analysis
3.2 Global Drug Detection and Analysis Sales Value by Type
3.2.1 Global Drug Detection and Analysis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drug Detection and Analysis Sales Value, by Type (2019-2030)
3.2.3 Global Drug Detection and Analysis Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Laboratory
4.1.3 Pharmaceutical company
4.2 Global Drug Detection and Analysis Sales Value by Application
4.2.1 Global Drug Detection and Analysis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drug Detection and Analysis Sales Value, by Application (2019-2030)
4.2.3 Global Drug Detection and Analysis Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Drug Detection and Analysis Sales Value by Region
5.1.1 Global Drug Detection and Analysis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drug Detection and Analysis Sales Value by Region (2019-2024)
5.1.3 Global Drug Detection and Analysis Sales Value by Region (2025-2030)
5.1.4 Global Drug Detection and Analysis Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Drug Detection and Analysis Sales Value, 2019-2030
5.2.2 North America Drug Detection and Analysis Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Drug Detection and Analysis Sales Value, 2019-2030
5.3.2 Europe Drug Detection and Analysis Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Drug Detection and Analysis Sales Value, 2019-2030
5.4.2 Asia Pacific Drug Detection and Analysis Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Drug Detection and Analysis Sales Value, 2019-2030
5.5.2 South America Drug Detection and Analysis Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Drug Detection and Analysis Sales Value, 2019-2030
5.6.2 Middle East & Africa Drug Detection and Analysis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drug Detection and Analysis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drug Detection and Analysis Sales Value
6.3 United States
6.3.1 United States Drug Detection and Analysis Sales Value, 2019-2030
6.3.2 United States Drug Detection and Analysis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drug Detection and Analysis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug Detection and Analysis Sales Value, 2019-2030
6.4.2 Europe Drug Detection and Analysis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drug Detection and Analysis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drug Detection and Analysis Sales Value, 2019-2030
6.5.2 China Drug Detection and Analysis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drug Detection and Analysis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drug Detection and Analysis Sales Value, 2019-2030
6.6.2 Japan Drug Detection and Analysis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drug Detection and Analysis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drug Detection and Analysis Sales Value, 2019-2030
6.7.2 South Korea Drug Detection and Analysis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drug Detection and Analysis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drug Detection and Analysis Sales Value, 2019-2030
6.8.2 Southeast Asia Drug Detection and Analysis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drug Detection and Analysis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drug Detection and Analysis Sales Value, 2019-2030
6.9.2 India Drug Detection and Analysis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drug Detection and Analysis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Element Materials Technology
7.1.1 Element Materials Technology Profile
7.1.2 Element Materials Technology Main Business
7.1.3 Element Materials Technology Drug Detection and Analysis Products, Services and Solutions
7.1.4 Element Materials Technology Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.1.5 Element Materials Technology Recent Developments
7.2 Intertek
7.2.1 Intertek Profile
7.2.2 Intertek Main Business
7.2.3 Intertek Drug Detection and Analysis Products, Services and Solutions
7.2.4 Intertek Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.2.5 Intertek Recent Developments
7.3 Microtrace LLC
7.3.1 Microtrace LLC Profile
7.3.2 Microtrace LLC Main Business
7.3.3 Microtrace LLC Drug Detection and Analysis Products, Services and Solutions
7.3.4 Microtrace LLC Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.3.5 LPD Lab Services Recent Developments
7.4 LPD Lab Services
7.4.1 LPD Lab Services Profile
7.4.2 LPD Lab Services Main Business
7.4.3 LPD Lab Services Drug Detection and Analysis Products, Services and Solutions
7.4.4 LPD Lab Services Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.4.5 LPD Lab Services Recent Developments
7.5 Reading Scientific Services
7.5.1 Reading Scientific Services Profile
7.5.2 Reading Scientific Services Main Business
7.5.3 Reading Scientific Services Drug Detection and Analysis Products, Services and Solutions
7.5.4 Reading Scientific Services Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.5.5 Reading Scientific Services Recent Developments
7.6 Triclinic Labs
7.6.1 Triclinic Labs Profile
7.6.2 Triclinic Labs Main Business
7.6.3 Triclinic Labs Drug Detection and Analysis Products, Services and Solutions
7.6.4 Triclinic Labs Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.6.5 Triclinic Labs Recent Developments
7.7 Gateway Analytical
7.7.1 Gateway Analytical Profile
7.7.2 Gateway Analytical Main Business
7.7.3 Gateway Analytical Drug Detection and Analysis Products, Services and Solutions
7.7.4 Gateway Analytical Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.7.5 Gateway Analytical Recent Developments
7.8 McCrone Group
7.8.1 McCrone Group Profile
7.8.2 McCrone Group Main Business
7.8.3 McCrone Group Drug Detection and Analysis Products, Services and Solutions
7.8.4 McCrone Group Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.8.5 McCrone Group Recent Developments
7.9 Avomeen
7.9.1 Avomeen Profile
7.9.2 Avomeen Main Business
7.9.3 Avomeen Drug Detection and Analysis Products, Services and Solutions
7.9.4 Avomeen Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.9.5 Avomeen Recent Developments
7.10 ALS Global
7.10.1 ALS Global Profile
7.10.2 ALS Global Main Business
7.10.3 ALS Global Drug Detection and Analysis Products, Services and Solutions
7.10.4 ALS Global Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.10.5 ALS Global Recent Developments
7.11 SGS SA
7.11.1 SGS SA Profile
7.11.2 SGS SA Main Business
7.11.3 SGS SA Drug Detection and Analysis Products, Services and Solutions
7.11.4 SGS SA Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.11.5 SGS SA Recent Developments
7.12 Eurofins Scientific
7.12.1 Eurofins Scientific Profile
7.12.2 Eurofins Scientific Main Business
7.12.3 Eurofins Scientific Drug Detection and Analysis Products, Services and Solutions
7.12.4 Eurofins Scientific Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.12.5 Eurofins Scientific Recent Developments
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Profile
7.13.2 Thermo Fisher Scientific Main Business
7.13.3 Thermo Fisher Scientific Drug Detection and Analysis Products, Services and Solutions
7.13.4 Thermo Fisher Scientific Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.13.5 Thermo Fisher Scientific Recent Developments
7.14 ChemCentre
7.14.1 ChemCentre Profile
7.14.2 ChemCentre Main Business
7.14.3 ChemCentre Drug Detection and Analysis Products, Services and Solutions
7.14.4 ChemCentre Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.14.5 ChemCentre Recent Developments
7.15 PerkinElmer
7.15.1 PerkinElmer Profile
7.15.2 PerkinElmer Main Business
7.15.3 PerkinElmer Drug Detection and Analysis Products, Services and Solutions
7.15.4 PerkinElmer Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.15.5 PerkinElmer Recent Developments
7.16 TUV SUD
7.16.1 TUV SUD Profile
7.16.2 TUV SUD Main Business
7.16.3 TUV SUD Drug Detection and Analysis Products, Services and Solutions
7.16.4 TUV SUD Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.16.5 TUV SUD Recent Developments
7.17 Bureau Veritas
7.17.1 Bureau Veritas Profile
7.17.2 Bureau Veritas Main Business
7.17.3 Bureau Veritas Drug Detection and Analysis Products, Services and Solutions
7.17.4 Bureau Veritas Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.17.5 Bureau Veritas Recent Developments
7.18 Charles River Laboratories
7.18.1 Charles River Laboratories Profile
7.18.2 Charles River Laboratories Main Business
7.18.3 Charles River Laboratories Drug Detection and Analysis Products, Services and Solutions
7.18.4 Charles River Laboratories Drug Detection and Analysis Revenue (US$ Million) & (2019-2024)
7.18.5 Charles River Laboratories Recent Developments
8 Industry Chain Analysis
8.1 Drug Detection and Analysis Industrial Chain
8.2 Drug Detection and Analysis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drug Detection and Analysis Sales Model
8.5.2 Sales Channel
8.5.3 Drug Detection and Analysis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Element Materials Technology
Intertek
Microtrace LLC
LPD Lab Services
Reading Scientific Services
Triclinic Labs
Gateway Analytical
McCrone Group
Avomeen
ALS Global
SGS SA
Eurofins Scientific
Thermo Fisher Scientific
ChemCentre
PerkinElmer
TUV SUD
Bureau Veritas
Charles River Laboratories
听
听
*If Applicable.
